Advancing Tomorrow's Cures Through Today's Policy

The Antibody Innovation Alliance unites biotech leaders to reshape FDA pathways and unlock federal research funding. Together, we're accelerating the next generation of antibody therapeutics.

45+
Member Biotech Companies
$2.3B
Combined R&D Investment
12
FDA Policy Reforms Championed
200+
Congressional Briefings Delivered

United for Innovation in Antibody Therapeutics

The Antibody Innovation Alliance represents the leading voices in next-generation antibody development. We bring industry, regulators, and policymakers together to remove barriers to innovation and accelerate life-changing therapies from lab to patient.

Our members span from breakthrough startups to established biotech powerhouses, collectively advancing over 150 antibody programs in clinical development. By advocating for streamlined FDA approval pathways and increased federal research investment, we're building the policy infrastructure that modern therapeutics demand.

What We Do

Federal Legislative Advocacy

We work directly with Congress to shape legislation that accelerates antibody therapeutics to market. Our team tracks policy developments, coordinates member testimony, and builds bipartisan coalitions around science-driven solutions.

Regulatory Policy Reform

We partner with the FDA to advance approval pathways tailored to antibody innovation. From expedited review programs to adaptive trial designs, we advocate for policies that reward scientific rigor without sacrificing speed.

Coalition Building

We unite biotech executives, patient advocates, and scientific leaders into a unified voice. Our coalition amplifies member priorities and creates strategic partnerships that drive meaningful policy change.

Why Antibody Innovation Alliance?

Industry-Led Strategy

We're built by biotech leaders who understand R&D timelines, clinical challenges, and market realities—ensuring our advocacy is both ambitious and grounded in science.

Direct Regulatory Access

Our established relationships with FDA leadership and key congressional committees give member companies direct influence on the policies that affect their pipelines.

Collective Power, Focused Voice

Members multiply their advocacy impact without duplicating efforts. We consolidate priorities across the industry and speak with unified authority on policy issues.

Transform Antibody Innovation Policy

Join the Alliance and help shape the regulatory and legislative landscape for next-generation therapeutics.

Become a Member

Contact Your Representative

Enter your ZIP code to find your elected officials and send them a message in seconds.

people have signed

Add Your Voice

Join thousands of advocates demanding action. Sign the petition to show your support.